Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Richard W. Simpson

Erratum To: GLP-1-dependent and Independent Effects and Molecular Mechanisms of a Dipeptidyl Peptidase 4 Inhibitor in Vascular Endothelial Cells

Molecular Biology Reports
MedicineGeneticsMolecular Biology
2012English

Related publications

Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina Through VE-cadherin Phosphorylation

Scientific Reports
Multidisciplinary
2016English

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid

2019English

Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, Against Cisplatin-Induced Nephrotoxicity in Mice

Mediators of Inflammation
ImmunologyCell Biology
2017English

Glucagon-Like Peptide-1 (GLP-1) Mediates the Protective Effects of Dipeptidyl Peptidase IV Inhibition on Pulmonary Hypertension

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2019English

Dipeptidyl Peptidase-4 (DPP-4; CD26)

Science-Business eXchange
2014English

cAMP-independent Effects of GLP-1 on Β Cells

Journal of Clinical Investigation
Medicine
2015English

Significance of Vascular Dipeptidyl Peptidase-4 Inhibition on Vascular Protection in Zucker Diabetic Fatty Rats

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2014English

Pharmacokinetic and Pharmacodynamic Interactions Between Metformin and a Novel Dipeptidyl Peptidase-4 Inhibitor, Evogliptin, in Healthy Subjects

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy